Oncopeptides AB (publ)

kr 1.74As of Sun 8 Nov 2026, 12:00 UTC
STO:ONCOHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (25.30%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.50)
PE TTM —
TSR TTM (69.35%)
Mkt cap kr 689.4M
ROIC (82.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.77
1.53%
(79.53%)
Buy 1|2|3|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.03
0.03
0.03
0.03
5.26%
21.12%
18.03%
24.84%
Revenuekr M
51.19
49.81
50.27
51.65
2.53%
1.55%
2.30%
0.43%
Peers (US$69.70M)
Cap (US$)
PE
86.51M
—
85.32M
22.67x
75.71M
—
Capital
TTM
5Y
10Y
Leveragex
1.564
0.145
0.121
EBIT/Intx
1.186
0.180
0.138
Own earn%
(45.59)
(280.91)
(225.78)
Sh yield%
16.04
45.34
46.99
Owners
Insiders/Inst%
7.00
75.85
Short interest%
4.34
SBC / revenue%
1.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
5–11
$1 testx
−0.3
Incr. ROIC%
14